Eargo (NASDAQ:EAR) Trading Down 3.6%

Shares of Eargo, Inc. (NASDAQ:EAR – Get Free Report) dropped 3.6% on Monday . The stock traded as low as $2.13 and last traded at $2.15. Approximately 25,946 shares were traded during trading, a decline of 53% from the average daily volume of 55,747 shares. The stock had previously closed at $2.23.

Eargo Price Performance

The company has a market cap of $44.61 million, a P/E ratio of -0.07 and a beta of 1.62. The stock has a 50-day moving average of $3.18 and a 200 day moving average of $4.30.

Get Eargo alerts:

Eargo (NASDAQ:EAR – Get Free Report) last issued its quarterly earnings results on Thursday, August 10th. The company reported ($1.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.97) by ($0.11). Eargo had a negative return on equity of 251.60% and a negative net margin of 347.20%. The company had revenue of $8.11 million during the quarter, compared to the consensus estimate of $8.20 million.

Institutional Trading of Eargo

Large investors have recently bought and sold shares of the business. Invesco Ltd. acquired a new stake in Eargo in the first quarter valued at about $55,000. Ergoteles LLC acquired a new stake in shares of Eargo during the first quarter valued at about $134,000. Rhumbline Advisers boosted its stake in shares of Eargo by 45.8% during the first quarter. Rhumbline Advisers now owns 28,172 shares of the company’s stock valued at $149,000 after purchasing an additional 8,855 shares in the last quarter. Gabelli Funds LLC boosted its stake in shares of Eargo by 143.7% during the first quarter. Gabelli Funds LLC now owns 48,737 shares of the company’s stock valued at $258,000 after purchasing an additional 28,737 shares in the last quarter. Finally, Virtu Financial LLC acquired a new stake in shares of Eargo during the second quarter valued at about $39,000. 80.53% of the stock is owned by institutional investors and hedge funds.

Eargo Company Profile

(Get Free Report)

Eargo, Inc, a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc and changed its name to Eargo, Inc in November 2014.

Further Reading

• Five stocks we like better than Eargo
• Insider Buying Explained: What Investors Need to Know
• 2 Must-Have Silicon Companies That Don’t Make Microchips
• Stock Analyst Ratings and Canadian Analyst Ratings
• Small Caps That Have Priced In A Hard Landing For Big Upside
• Investing in Travel Stocks Benefits
• This May Have Ended Alibaba’s Winter, But Is It Time To Buy?

Receive News & Ratings for Eargo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eargo and related companies with MarketBeat.com's FREE daily email newsletter.